205 related articles for article (PubMed ID: 38002490)
1. Rab Geranylgeranyltransferase Subunit Beta as a Potential Indicator to Assess the Progression of Amyotrophic Lateral Sclerosis.
Yang J; Xin C; Huo J; Li X; Dong H; Liu Q; Li R; Liu Y
Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002490
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of intrathecal injection of AAV9-RabGGTB-GFP
Gao T; Huo J; Xin C; Yang J; Liu Q; Dong H; Li R; Liu Y
Front Aging Neurosci; 2023; 15():1092607. PubMed ID: 36967828
[TBL] [Abstract][Full Text] [Related]
3. RABGGTB plays a critical role in ALS pathogenesis.
Ma H; Huo J; Xin C; Yang J; Liu Q; Dong H; Li R; Liu Y
Brain Res Bull; 2024 Jan; 206():110833. PubMed ID: 38042502
[TBL] [Abstract][Full Text] [Related]
4. Eosinophils at diagnosis are elevated in amyotrophic lateral sclerosis.
Yang J; Liu T; Zhang L; Li X; Du FP; Liu Q; Dong H; Liu Y
Front Neurol; 2023; 14():1289467. PubMed ID: 38187158
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein levels in patients with amyotrophic lateral sclerosis: A systematic review.
Kharel S; Ojha R; Preethish-Kumar V; Bhagat R
Brain Behav; 2022 Mar; 12(3):e2532. PubMed ID: 35201675
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression.
Murdock BJ; Zhou T; Kashlan SR; Little RJ; Goutman SA; Feldman EL
JAMA Neurol; 2017 Dec; 74(12):1446-1454. PubMed ID: 28973548
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of disease progression rate and related factors in amyotrophic lateral sclerosis patients at initial visit].
Zhang JH; Wang HF; Yang F; He ZQ; Feng F; Li M; Bai JM; Wang HR; Huang XS
Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):222-227. PubMed ID: 35042292
[No Abstract] [Full Text] [Related]
8. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
Pirola A; De Mattia E; Lizio A; Sannicolò G; Carraro E; Rao F; Sansone V; Lunetta C
Clin Neurol Neurosurg; 2019 Sep; 184():105456. PubMed ID: 31382080
[TBL] [Abstract][Full Text] [Related]
9. Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).
Mandrioli J; Crippa V; Cereda C; Bonetto V; Zucchi E; Gessani A; Ceroni M; Chio A; D'Amico R; Monsurrò MR; Riva N; Sabatelli M; Silani V; Simone IL; Sorarù G; Provenzani A; D'Agostino VG; Carra S; Poletti A
BMJ Open; 2019 May; 9(5):e028486. PubMed ID: 31152038
[TBL] [Abstract][Full Text] [Related]
10. Monocyte CD14 and HLA-DR expression increases with disease duration and severity in amyotrophic lateral sclerosis.
Mcgill RB; Steyn FJ; Ngo ST; Thorpe KA; Heggie S; Henderson RD; Mccombe PA; Woodruff TM
Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):430-437. PubMed ID: 34396845
[No Abstract] [Full Text] [Related]
11. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
12. Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosis.
Hannaford A; Byth K; Pavey N; Henderson RD; Mathers S; Needham M; Schultz D; Menon P; Kiernan MC; Vucic S
Muscle Nerve; 2023 Jan; 67(1):17-24. PubMed ID: 36214183
[TBL] [Abstract][Full Text] [Related]
13. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
[TBL] [Abstract][Full Text] [Related]
14. Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis.
Murdock BJ; Bender DE; Kashlan SR; Figueroa-Romero C; Backus C; Callaghan BC; Goutman SA; Feldman EL
Neurol Neuroimmunol Neuroinflamm; 2016 Aug; 3(4):e242. PubMed ID: 27308304
[TBL] [Abstract][Full Text] [Related]
15. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
[TBL] [Abstract][Full Text] [Related]
16. Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial).
Morimoto S; Takahashi S; Fukushima K; Saya H; Suzuki N; Aoki M; Okano H; Nakahara J
Regen Ther; 2019 Dec; 11():143-166. PubMed ID: 31384636
[TBL] [Abstract][Full Text] [Related]
17. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
[TBL] [Abstract][Full Text] [Related]
18. Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research.
Araujo BG; Souza E Silva LF; de Barros Torresi JL; Siena A; Valerio BCO; Brito MD; Rosenstock TR
Mol Neurobiol; 2020 Dec; 57(12):5084-5102. PubMed ID: 32840822
[TBL] [Abstract][Full Text] [Related]
19. Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis.
Agnello L; Colletti T; Lo Sasso B; Vidali M; Spataro R; Gambino CM; Giglio RV; Piccoli T; Bivona G; La Bella V; Ciaccio M
Eur J Neurol; 2021 Jun; 28(6):1868-1875. PubMed ID: 33638255
[TBL] [Abstract][Full Text] [Related]
20. Role of the immune system in amyotrophic lateral sclerosis. Analysis of the natural killer cells and other circulating lymphocytes in a cohort of ALS patients.
Piccoli T; Castro F; La Bella V; Meraviglia S; Di Simone M; Salemi G; Dieli F; Spataro R
BMC Neurol; 2023 Jun; 23(1):222. PubMed ID: 37296379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
